Lista de obras - Shlomo Melmed - Dominio Público Uruguay

A Pituitary Society update to acromegaly management guidelines

artículo científico publicado en 2020

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

artículo científico publicado en 2005

A structural and functional acromegaly classification

artículo científico publicado en 2015

Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis

artículo científico publicado en 2014

Acromegaly pathogenesis and treatment

artículo científico publicado en 2009

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).

artículo científico publicado en 2014

Angiogenesis in endocrine tumors.

artículo científico publicado en 2003

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation ⬇️

artículo científico publicado el 6 de octubre de 2011

Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients

artículo científico publicado en 2014

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

artículo científico publicado en 2012

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly

artículo científico publicado en 2003

Clinical, quality of life, and economic value of acromegaly disease control ⬇️

artículo científico publicado el 1 de septiembre de 2011

Current status and future opportunities for controlling acromegaly

artículo científico publicado en 2002

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

artículo científico publicado en 2015

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

artículo científico publicado en 2011

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

artículo científico publicado en 2015

Expert consensus document: A consensus on the medical treatment of acromegaly

artículo científico publicado en 2014

Functional role of estrogen in pituitary tumor pathogenesis

artículo científico publicado en 2002

Genomic Characterization of Human and Rat Prolactinomas ⬇️

artículo científico publicado el 25 de mayo de 2012

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

artículo científico publicado en 2016

Growth hormone in the tumor microenvironment

artículo científico publicado en 2019

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

artículo científico publicado en 2010

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

artículo científico publicado en 2008

Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth ⬇️

artículo científico publicado el 25 de marzo de 2011

Mechanisms for pituitary tumorigenesis: the plastic pituitary

artículo científico publicado en 2003

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

artículo científico publicado en 2012

Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules

artículo científico publicado en 2002

Molecular targets in pituitary tumours

artículo científico publicado en 2004

Multidisciplinary management of acromegaly: A consensus

artículo científico publicado en 2020

Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm

artículo científico publicado en 2003

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas ⬇️

artículo científico publicado el 1 de mayo de 2003

PTTG1 attenuates drug-induced cellular senescence

artículo científico publicado en 2011

Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults

scientific article published on 01 June 2019

Pituitary Magnetic Resonance Imaging for Sellar and Parasellar Masses: Ten-Year Experience in 2598 Patients ⬇️

artículo científico publicado el 6 de abril de 2011

Pituitary adenoma growth: a model for cellular senescence and cytokine action

artículo científico publicado en 2009

Pituitary somatostatin receptor signaling

artículo científico publicado en 2010

Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes

artículo científico publicado en 2003

Pituitary tumor transforming gene: an update

artículo científico publicado en 2004

Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics

artículo científico publicado en 2014

Pituitary tumors

artículo científico publicado en 2015

Pituitary-Tumor Endocrinopathies

artículo científico publicado en 2020

Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica

scientific article published on 29 November 2020

Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion

artículo científico publicado en 2006

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

artículo científico publicado en 2009

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

artículo científico publicado en 2015

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

artículo científico publicado en 2015

Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes

artículo científico publicado en 2010

Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases

artículo científico publicado en 2013

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

artículo científico publicado en 2012

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor ⬇️

artículo científico publicado el 2 de mayo de 2011

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome

artículo científico publicado en 2010

Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion

artículo científico publicado en 2011

Lista de obras de Shlomo Melmed

A Pituitary Society update to acromegaly management guidelines

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

A structural and functional acromegaly classification

Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis

Acromegaly pathogenesis and treatment

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).

Angiogenesis in endocrine tumors.

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation ⬇️

Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly

Clinical, quality of life, and economic value of acromegaly disease control ⬇️

Current status and future opportunities for controlling acromegaly

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

Expert consensus document: A consensus on the medical treatment of acromegaly

Functional role of estrogen in pituitary tumor pathogenesis

Genomic Characterization of Human and Rat Prolactinomas ⬇️

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Growth hormone in the tumor microenvironment

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth ⬇️

Mechanisms for pituitary tumorigenesis: the plastic pituitary

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules

Molecular targets in pituitary tumours

Multidisciplinary management of acromegaly: A consensus

Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas ⬇️

PTTG1 attenuates drug-induced cellular senescence

Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults

Pituitary Magnetic Resonance Imaging for Sellar and Parasellar Masses: Ten-Year Experience in 2598 Patients ⬇️

Pituitary adenoma growth: a model for cellular senescence and cytokine action

Pituitary somatostatin receptor signaling

Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes

Pituitary tumor transforming gene: an update

Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics

Pituitary tumors

Pituitary-Tumor Endocrinopathies

Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica

Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes

Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor ⬇️

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome

Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion